Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Lehmann

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Pathology|October 12, 2013
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypesBrian D Lehmann, Jennifer A Pietenpol
Breast (Edinburgh, Scotland)|August 9, 2015
Clinical implications of molecular heterogeneity in triple negative breast cancerBrian D Lehmann, Jennifer A Pietenpol
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Targeting mutant p53 in human tumorsBrian D Lehmann, Jennifer A Pietenpol
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Triple-negative breast cancer: molecular subtypes and new targets for therapyBrian D Lehmann, Jennifer A Pietenpol, Antoinette R Tan
International Journal of Genomics|March 2, 2017
The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic StudiesPan Zhang, Brian D Lehmann, Yu Shyr, et al.
Cancer Biology & Therapy|December 7, 2007
Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathwayBrian D Lehmann, James A McCubrey, David M Terrian
Gigascience|December 9, 2025
An Integrative Multi-Omics Random Forest Framework for Robust Biomarker DiscoveryWei Zhang, Hanchen Huang, Lily Wang, et al.
Cancers|May 16, 2023
Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant ChemotherapyWei Zhang, Emma Li, Lily Wang, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
An Integrative Multi-Omics Random Forest Framework for Robust Biomarker DiscoveryWei Zhang, Hanchen Huang, Lily Wang, et al.
Breast Cancer Research : BCR|January 24, 2013
Patient-derived breast tumor xenografts facilitating personalized cancer therapyMelissa D Landis, Brian D Lehmann, Jennifer A Pietenpol, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Pathology|October 12, 2013
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypesBrian D Lehmann, Jennifer A Pietenpol
Breast (Edinburgh, Scotland)|August 9, 2015
Clinical implications of molecular heterogeneity in triple negative breast cancerBrian D Lehmann, Jennifer A Pietenpol
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Targeting mutant p53 in human tumorsBrian D Lehmann, Jennifer A Pietenpol
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Triple-negative breast cancer: molecular subtypes and new targets for therapyBrian D Lehmann, Jennifer A Pietenpol, Antoinette R Tan
International Journal of Genomics|March 2, 2017
The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic StudiesPan Zhang, Brian D Lehmann, Yu Shyr, et al.
Cancer Biology & Therapy|December 7, 2007
Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathwayBrian D Lehmann, James A McCubrey, David M Terrian
Gigascience|December 9, 2025
An Integrative Multi-Omics Random Forest Framework for Robust Biomarker DiscoveryWei Zhang, Hanchen Huang, Lily Wang, et al.
Cancers|May 16, 2023
Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant ChemotherapyWei Zhang, Emma Li, Lily Wang, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
An Integrative Multi-Omics Random Forest Framework for Robust Biomarker DiscoveryWei Zhang, Hanchen Huang, Lily Wang, et al.
Breast Cancer Research : BCR|January 24, 2013
Patient-derived breast tumor xenografts facilitating personalized cancer therapyMelissa D Landis, Brian D Lehmann, Jennifer A Pietenpol, et al.
Pageof 7